Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2020 Financial Results
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care and dermatological conditions today announced financial results for fiscal year 2020 and the fourth quarter ended March 31, 2020. “We began this fiscal year with a goal of reducing our losses and cash burn and are pleased with an 75% drop in our net loss whil